American Board of Psychiatry and Neurology (ABPN) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the American Board of Psychiatry and Neurology Exam. Practice with questions and detailed explanations to boost your confidence. Ensure your readiness for the big day!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Which sleep agent has the longest half-life, increasing the risk of next-day drowsiness?

  1. Zolpidem

  2. Eszopiclone

  3. Ramelteon

  4. Zaleplon

The correct answer is: Eszopiclone

Eszopiclone is known to have the longest half-life among the sleep agents listed, typically ranging from 6 to 9 hours, although it can vary in individuals. This extended half-life can result in the drug remaining in the body longer than others, which increases the likelihood of experiencing next-day drowsiness and cognitive impairment. In contrast, other agents in the list have shorter half-lives: Zolpidem generally has a half-life of about 2 to 3 hours, making it less likely to contribute to next-day sedation. Ramelteon, a melatonin receptor agonist, also has a relatively short duration of action, which tends to minimize lingering effects the following day. Zaleplon has an even shorter half-life of approximately 1 hour, allowing it to be rapidly eliminated from the body and further reducing the risk of residual sedation the next day. Thus, due to Eszopiclone's longer half-life, it poses a higher risk for patients to experience next-morning drowsiness compared to the other options listed.